AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC)

• Main Authors: Huynh, H, Ngo, V.C., Soo, K.C., Koong, H.N., Poon, D., Choo, S.P., Toh, H.C., Thng, C.H., Chow, P., Ong, H.S., Chung, A., Goh, B.C., Smith, P.D.
• Other Authors: PHARMACOLOGY
• Format: Article
• Published: 2011
• Subjects: Angiogenesis; Apoptosis; Combined therapy; Growth inhibition; HCC xenografts
• Online Access: http://scholarbank.nus.edu.sg/handle/10635/27256
• Institution: National University of Singapore

10.1016/j.jhep.2009.10.008